Besides CAR-T-induced CRS in adults and children,29,146 many studies also showed that the serum of IL-6 increased remarkably in patients with COVID-19.147–149 Besides, targeting IL-6 pathway has led to innovative therapeutic approaches for various rheumatic diseases and related therapy is on the way. This evidence concerns the gene IL6 and congenital rubella syndrome.